AMT vs PTGX · P/E 31, rev $10.64B vs rev $269.8M
American Tower Corp (AMT) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
American Tower Corp (AMT) is a reit - specialty company listed on US.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported AMT revenue for 2025-12-31 was $10.64B. Net income was $2.63B. Revenue was up 317.8% from 2024-12-31 to 2025-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
AMT currently screens at market cap $90.44B and trailing P/E 31.4. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the AMT and PTGX stock pages for the full models.
Not investment advice.